Quickly
JOHNSON JOHNSON
North Korean Hackers Targeted Systems of COVID-19 Vaccine Developers Johnson & Johnson, Novavax: Report
COVID-19 Vaccine Update: Johnson & Johnson Begins Phase 3 of Two-Dose Trials of Its Vaccine
COVID-19 Vaccine Update: Johnson & Johnson Says Vaccine Could Be Available from January 2021; AstraZeneca Produces Robust Immune Response
COVID-19 Vaccine Development: Major Updates on Oxford-AstraZeneca, Johnson & Johnson, Sputnik V, Bharat Biotech & Sinopharm Candidates
COVID-19 Vaccine Update: Johnson & Johnson Pauses Vaccine Trial After Volunteer Falls Ill
COVID-19 Vaccine Update: Johnson & Johnson Pauses Coronavirus Vaccine Trials Due to Unexplained Illness in a Study Participant
COVID-19 Vaccine Latest News Update: Anti-Coronavirus Drug by Johnson & Johnson Produces Strong Immune Response In Early Trial
Johnson & Johnson Kicks Off COVID-19 Vaccine Final Trials on 60,000 Volunteers, Results Expected by Early 2021
COVID-19 Vaccine Update: Johnson & Johnson Vaccine Prevents Severe Clinical Infection in Hamsters, Says Study
COVID-19 Vaccine Update: UK Strikes Deals for 90 Million More Coronavirus Vaccine Doses from Novavax and Johnson & Johnson
COVID-19 Vaccine Update: India's Biological E Signs Pact With Johnson & Johnson for Coronavirus Vaccine Production
Johnson & Johnson's Experimental COVID-19 Vaccine Protects Monkeys in a Single Dose, US Firm Kicks-Off Human Safety Trials
